Skip to main content

Table 3 WNT1, WT1, RSPO1, P16, and SDC1 expression in invasive ductal carcinoma in relation to clinicopathological parameters (n = number of cases)

From: Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast

 

SDC1+ ** n

SDC1-** n

P value

WNT1+ n

WNT1- n

P value

WT1+ n

WT1- n

P value

RSPO1+ n

RSPO1- n

P value

P16+ n

P16- n

P value

T stage

  

0.087

  

0.201

  

0.073

  

1.000

  

0.346

1

11

13

 

22

5

 

15

11

 

22

1

 

9

16

 

2–3

18

55

 

48

25

 

24

45

 

64

5

 

17

55

 

N stage

  

0.111

  

0.171

  

0.482

  

0.237

  

1.000

0

16

24

 

33

9

 

19

22

 

38

1

 

11

29

 

1–3

13

44

 

37

21

 

20

34

 

48

5

 

15

42

 

Grade

  

0.052

  

0.147

  

0.025*

  

0.694

  

0.911

1–2

21

33

 

43

13

 

28

26

 

48

4

 

14

41

 

3

8

35

 

27

17

 

11

30

 

38

2

 

12

30

 

Estrogen

  

0.035*

  

0.442

  

0.577

  

0.643

  

0.104

receptor

   

45

17

 

25

34

 

55

3

 

13

48

 

Positive

14

47

 

18

11

 

9

18

 

24

2

 

11

16

 

Negative

13

14

             

Progesterone

  

0.124

  

0.276

  

0.545

  

0.019*

  

1.000

receptor

   

49

18

 

27

37

 

60

1

 

18

47

 

Positive

23

42

 

14

10

 

7

15

 

19

4

 

6

17

 

Negative

4

19

             
  1. *P <0.05.
  2. **Membranous immunoreactivity of the antibody for SDC1 ectodomain.